These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9853310)

  • 1. A study of metabolites isolated from the urine samples of cats and dogs administered orbifloxacin.
    Matsumoto S; Takahashi M; Kitadai N; Katae H
    J Vet Med Sci; 1998 Nov; 60(11):1259-61. PubMed ID: 9853310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of urinary pharmacokinetics and pharmacodynamics of orbifloxacin in healthy dogs with ex vivo modelling.
    Shimizu T; Harada K; Manabe S; Tsukamoto T; Ito N; Hikasa Y
    J Med Microbiol; 2017 May; 66(5):616-621. PubMed ID: 28470147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of minimum biofilm eradication concentrations of orbifloxacin for canine bacterial uropathogens over different treatment periods.
    Shimizu T; Harada K
    Microbiol Immunol; 2017 Jan; 61(1):17-22. PubMed ID: 28042660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of metabolites isolated from urine samples of pigs and calves administered orbifloxacin.
    Matsumoto S; Nakai M; Yoshida M; Katae H
    J Vet Pharmacol Ther; 1999 Aug; 22(4):286-9. PubMed ID: 10499242
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics in plasma and alveolar regions of a healthy calf intramuscularly administered a single dose of orbifloxacin.
    Kuramae T; Ishikawa S; Kono A; Hobo S
    J Vet Med Sci; 2022 Mar; 84(3):400-405. PubMed ID: 35095059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue concentrations of enrofloxacin and ciprofloxacin in anesthetized dogs following single intravenous administration.
    Boothe DM; Boeckh A; Boothe HW; Wilkie S
    Vet Ther; 2001; 2(2):120-8. PubMed ID: 19753704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic integration of orbifloxacin in Japanese quail (Coturnix japonica) following oral and intravenous administration.
    Hawkins MG; Taylor IT; Byrne BA; Armstrong RD; Tell LA
    J Vet Pharmacol Ther; 2011 Aug; 34(4):350-8. PubMed ID: 20950349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats.
    Boothe DM; Boeckh A; Simpson RB; Dubose K
    J Vet Intern Med; 2006; 20(6):1297-306. PubMed ID: 17186841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of orbifloxacin in crucian carp (Carassius auratus) after intravenous and intramuscular administration.
    Yang F; Yang F; Wang G; Shi W; Kong T; Yang P; Bai D; Zhou B
    J Vet Pharmacol Ther; 2018 Aug; 41(4):599-604. PubMed ID: 29465160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of orbifloxacin in Korean Hanwoo cattle.
    Elias G; Lee JS; Hwang MH; Park YS; Cho KH; Kim YH; Park SC
    J Vet Pharmacol Ther; 2009 Jun; 32(3):219-28. PubMed ID: 19646085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of plasma and skin concentrations of orbifloxacin in dogs with clinically normal skin and dogs with pyoderma.
    Kay-Mugford PA; Weingarten AJ; Ngoh M; Zolynas R; White A; Katz T; Simmons R; Varma KJ
    Vet Ther; 2002; 3(4):402-8. PubMed ID: 12584677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of rapidly growing mycobacteria isolated from cats and dogs, to ciprofloxacin, enrofloxacin and moxifloxacin.
    Govendir M; Hansen T; Kimble B; Norris JM; Baral RM; Wigney DI; Gottlieb S; Malik R
    Vet Microbiol; 2011 Jan; 147(1-2):113-8. PubMed ID: 20619975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and milk distribution characteristics of orbifloxacin following intravenous and intramuscular injection in lactating ewes.
    Goudah A; Cho HJ; Shin HC; Shim JH; Regmi NL; Shimoda M; Abd El-Aty AM
    J Vet Pharmacol Ther; 2009 Aug; 32(4):338-44. PubMed ID: 19614838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the crystallization potential of urine from cats and dogs with respect to calcium oxalate and magnesium ammonium phosphate (struvite).
    Robertson WG; Jones JS; Heaton MA; Stevenson AE; Markwell PJ
    J Nutr; 2002 Jun; 132(6 Suppl 2):1637S-41S. PubMed ID: 12042478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of several fluoroquinolones on hepatic microsomal cytochrome P-450 1A activities in dogs.
    Regmi NL; Abd El-Aty AM; Kuroha M; Nakamura M; Shimoda M
    J Vet Pharmacol Ther; 2005 Dec; 28(6):553-7. PubMed ID: 16343288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative analysis of potential metabolites and degradation products of a new antiinfective drug in rat urine, using HPLC with radiochemical detection and HPLC-mass spectrometry.
    Iavarone L; Scandola M; Pugnaghi F; Grossi P
    J Pharm Biomed Anal; 1995 Apr; 13(4-5):607-14. PubMed ID: 9696576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant prevention concentration and phenotypic and molecular basis of fluoroquinolone resistance in clinical isolates and in vitro-selected mutants of Escherichia coli from dogs.
    Gebru E; Damte D; Choi MJ; Lee SJ; Kim YH; Park SC
    Vet Microbiol; 2012 Jan; 154(3-4):384-94. PubMed ID: 21893387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and milk penetration of orbifloxacin after intravenous, subcutaneous, and intramuscular administration to lactating goats.
    Marín P; Escudero E; Fernández-Varón E; Cárceles CM
    J Dairy Sci; 2007 Sep; 90(9):4219-25. PubMed ID: 17699040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches for application of sub and supercritical fluid extraction for quantification of orbifloxacin from plasma and milk: application to disposition kinetics.
    Abd El-Aty AM; Choi JH; Ko MW; Khay S; Goudah A; Shin HC; Kim JS; Chang BJ; Lee CH; Shim JH
    Anal Chim Acta; 2009 Jan; 631(1):108-15. PubMed ID: 19046687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.